RxDoctor Payments Data

Sathish Mohan, MD

Vascular Surgery · Newport News, VANPI 1447679782

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (33.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 57.3% of the total. Reporting peaked in 2022 at $7,850 and has fallen 93.3% since, to $527 in 2025.

$15,140in general payments, 2019–2025

Across 157 payments — averaging $96.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Silk Road Medical, Inc.$3K
  • Getinge USA Sales, LLC$1K
  • Philips North America LLC$744
  • Cook Medical LLC$375
  • Inari Medical, Inc.$296
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$9306%
  • Speaking & faculty fees$2,60017%
  • Grants$1,55310%
  • Travel & lodging$5,07834%
  • Food & beverage$4,97833%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,140 in reported general payments places this provider in the 65th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$174,515
Medicare patients
374
Services billed
1,621

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate65$569
Atorvastatin Calcium39$316
Cilostazol11$258
Oxycodone Hcl18$87

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →